BCX — Bioceltix SA Balance Sheet
0.000.00%
Last trade - 00:00
- PLN278.74m
- PLN264.36m
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | PROSPECTUS | ARS | ARS | ARS |
Standards: | PAS | PAS | PAS | PAS |
Status: | Final | Final | Final | Final |
Cash | ||||
Cash and Short Term Investments | 1.1 | 3.2 | 6.05 | 4.12 |
Net Total Accounts Receivable | ||||
Net Total Receivables | 0.636 | 0.191 | 0.444 | 0.229 |
Total Inventory | ||||
Total Other Current Assets | ||||
Total Current Assets | 1.75 | 3.42 | 6.51 | 4.36 |
Net Property, Plant And Equipment | 0.641 | 1.13 | 1.53 | 1.46 |
Net Intangible Assets | ||||
Long Term Notes Receivable | ||||
Other Long Term Assets | ||||
Total Assets | 3.23 | 4.8 | 8.2 | 7.65 |
Accounts Payable | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Current Portion of Long Term Debt / Capital Leases | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 1.32 | 1.33 | 1.91 | 2.25 |
Capital Lease Obligations | ||||
Total Long Term Debt | ||||
Total Debt | ||||
Deferred Income Tax | ||||
Total Other Liabilities | ||||
Total Liabilities | 1.32 | 1.48 | 2.2 | 2.5 |
Common Stock | ||||
Additional Paid In Capital | ||||
Retained Earnings (Accumulated Deficit) | ||||
Other Equity | ||||
Total Equity | 1.91 | 3.32 | 6 | 5.15 |
Total Liabilities & Shareholders' Equity | 3.23 | 4.8 | 8.2 | 7.65 |
Total Common Shares Outstanding |